Specifically, we aimed to determine the association between Fn density and key clinical, pathological, and immune features, such as tumor grade, peritoneal tumor burden, and immune cell infiltration (CD3+ and CD8+ T cells, M1-/M2-like macrophages) and oncologic outcomes (treatment response and survival). This evidence concerns the gene CD8A and neoplasm.